Loading clinical trials...
Loading clinical trials...
Can the Betatrophin be a Reliable Marker of Insulin Resistance in Normal Weight and Overweight Women With Polycystic Ovary Syndrome?
Conditions
Interventions
serum marker levels
Locations
1
Turkey (Türkiye)
Kayseri Doğumevi
Kocasinan, Kayseri, Turkey (Türkiye)
Start Date
January 1, 2018
Primary Completion Date
July 30, 2019
Completion Date
December 30, 2019
Last Updated
June 26, 2020
NCT07472881
NCT01143454
NCT07483723
NCT06793098
NCT06793085
NCT07010757
Lead Sponsor
Hatice Akkaya
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions